Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson’s Disease
Junjun Zhao, Shuqing Yu, Yan Zheng, et al.
Molecular Neurobiology (2016) Vol. 54, Iss. 2, pp. 1404-1418
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Parkinson’s Disease: From Pathogenesis to Pharmacogenomics
Ramón Cacabelos
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 3, pp. 551-551
Open Access | Times Cited: 497
Oxidative stress and cellular pathologies in Parkinson’s disease
Lesly Puspita, Sun Young Chung, Jaewon Shim
Molecular Brain (2017) Vol. 10, Iss. 1
Open Access | Times Cited: 415
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs
Delphine Charvin, Rossella Medori, Robert A. Hauser, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 11, pp. 804-822
Closed Access | Times Cited: 243
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, et al.
Journal of Drug Delivery Science and Technology (2017) Vol. 43, pp. 295-310
Closed Access | Times Cited: 120
Cellular stress alters 3′UTR landscape through alternative polyadenylation and isoform-specific degradation
Dinghai Zheng, Ruijia Wang, Qingbao Ding, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
Huiyuan Zhao, Cui Wang, Nan Zhao, et al.
Journal of Chromatography B (2018) Vol. 1081-1082, pp. 101-108
Open Access | Times Cited: 95
Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics
Amrita Kulkarni, Preeti Kumari, Kamatham Pushpa Tryphena, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101816-101816
Closed Access | Times Cited: 39
Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases
Yu Xiang, Swapna Naik, Liyun Zhao, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 4, pp. 1404-1445
Closed Access | Times Cited: 7
Aptamer and its applications in neurodegenerative diseases
Jing Qu, Shuqing Yu, Zheng Yuan, et al.
Cellular and Molecular Life Sciences (2016) Vol. 74, Iss. 4, pp. 683-695
Closed Access | Times Cited: 54
Therapeutic target enzymes inhibitory potential, antioxidant activity, and rosmarinic acid content of Echium amoenum
Behvar Asghari, Sudabeh Mafakheri, M.M. Zarrabi, et al.
South African Journal of Botany (2018) Vol. 120, pp. 191-197
Open Access | Times Cited: 52
Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease
Jesús Calahorra, Montserrat Porta de la Riva, Esther Martínez‐Lara, et al.
Neurobiology of Aging (2019) Vol. 82, pp. 60-68
Closed Access | Times Cited: 50
Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress—Related Neurodegeneration
Cristina Angeloni, Martina Gatti, Cecilia Prata, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3299-3299
Open Access | Times Cited: 40
Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders
Islauddin Khan, Preeti Kumari, Valencia Fernandes, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 7, pp. 2075-2095
Closed Access | Times Cited: 37
Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A
Lijia Yu, Xijin Wang, Han-Qing Chen, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 40
Parkinson's disease‐related DJ‐1 modulates the expression of uncoupling protein 4 against oxidative stress
Shaoqing Xu, Xiaodong Yang, Yiwei Qian, et al.
Journal of Neurochemistry (2018) Vol. 145, Iss. 4, pp. 312-322
Open Access | Times Cited: 40
Pink1 regulates FKBP5 interaction with AKT/PHLPP and protects neurons from neurotoxin stress induced by MPP+
Wassamon Boonying, Alvin Joselin, En Huang, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 3, pp. 312-329
Open Access | Times Cited: 40
Anesthesia and surgery induce delirium-like behavior in susceptible mice: the role of oxidative stress.
Jie Zhang, Jie Gao, Guojun Guo, et al.
PubMed (2018) Vol. 10, Iss. 8, pp. 2435-2444
Closed Access | Times Cited: 39
GPR39 protects against corticosterone-induced neuronal injury in hippocampal cells through the CREB-BDNF signaling pathway
Fengfeng Mo, Yuxiao Tang, Peng Du, et al.
Journal of Affective Disorders (2020) Vol. 272, pp. 474-484
Closed Access | Times Cited: 36
Oxidative Modification of Proteins: From Damage to Catalysis, Signaling, and Beyond
Marilene Demasi, Ohára Augusto, Etelvino José Henriques Bechara, et al.
Antioxidants and Redox Signaling (2021) Vol. 35, Iss. 12, pp. 1016-1080
Open Access | Times Cited: 31
Novel insights into the role of circular RNAs in Parkinson disease: An emerging renaissance in the management of neurodegenerative diseases
Zahra Dorostgou, Negar Yadegar, Zeynab Dorostgou, et al.
Journal of Neuroscience Research (2022) Vol. 100, Iss. 9, pp. 1775-1790
Closed Access | Times Cited: 22
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk
Stefano Caproni, Alessio Di Fonzo, Carlo Colosimo
Parkinson s Disease (2025) Vol. 2025, Iss. 1
Open Access
Batryticatus Bombyx Protects Dopaminergic Neurons against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
Hye-Sun Lim, Joong‐Sun Kim, Byeong Cheol Moon, et al.
Antioxidants (2019) Vol. 8, Iss. 12, pp. 574-574
Open Access | Times Cited: 31
Advances in the study of mechanisms underlying olfactory dysfunction in obstructive sleep apnea:a narrative review
Qihang Zhang, Guangling Zhang, Pengfei Ba, et al.
Sleep and Biological Rhythms (2025)
Open Access
Salidroside Protects Dopaminergic Neurons by Preserving Complex I Activity via DJ-1/Nrf2-Mediated Antioxidant Pathway
Ruru Li, Songhai Wang, Tao Li, et al.
Parkinson s Disease (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top